Current issues in immunomodulatory treatment of multiple sclerosis

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Neurology

• Publication date

  2006-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00415-006-1108-9PMID 16477485
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiple sclerosis diagnostic criteria: three years later

  2005cited by this paper
• Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis

  2005cited by this paper
• Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange.

  2005cited by this paper
• The reproductive effects of beta interferon therapy in pregnancy

  2005cited by this paper
• Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

  2005cited by this paper
• The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing–remitting multiple sclerosis patients

  2005cited by this paper
• Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences.

  2005cited by this paper
• Treatment Optimization in Multiple Sclerosis*

  2004cited by this paper
• Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis

  2004cited by this paper
• Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis

  2004cited by this paper
• Escalating immunotherapy of multiple sclerosis

  2004cited by this paper
• Plasma exchange for severe optic neuritis

  2004cited by this paper
• Escalating immunotherapy of multiple sclerosis--new aspects and practical application.

  2004cited by this paper
• Spinal cord abnormalities in recently diagnosed MS patients

  2004cited by this paper
• New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes

  2003cited by this paper
• The diagnosis of primary progressive multiple sclerosis.

  2003cited by this paper
• Multiple sclerosis and optic neuritis: CCR5 and CXCR3 expressing T cells are augmented in blood and cerebrospinal fluid

  2002cited by this paper
• Diagnostic criteria for multiple sclerosis.

  2001cited by this paper
• Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

  2001cited by this paper
• Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.

  2000cited by this paper
• [MRI follow-up in multiple sclerosis. A guideline for quality assurance].

  1999cited by this paper
• MRT-Verlaufsuntersuchungen bei multipler Sklerose. Ein Leitfaden für die Qualitätssicherung

  1999cited by this paper
• A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease

  1999cited by this paper

• Anesthesia in a Pregnant Patient with Multiple Sclerosis and Spinal Fusion

  2018cites this paper
• Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery

  2017cites this paper
• Entzündiche Erkrankungen des Nervensystems

  2014cites this paper
• The influence of fear of falling on gait variability: results from a large elderly population-based cross-sectional study

  2014cites this paper
• Hyperbaric Oxygen Therapy for Multiple Sclerosis

  2010cites this paper
• Immunopharmacological role of the Leukotriene Receptor Antagonists and inhibitors of leukotrienes generating enzymes in Multiple Sclerosis

  2010cites this paper
• Prostaglandins in pathogenesis and treatment of multiple sclerosis

  2010cites this paper
• Entzündliche und immunvermittelte Erkrankungen des Nervensystems

  2009cites this paper
• Changes in the activation level of NF-kappa B in lymphocytes of MS patients during glucocorticoid pulse therapy.

  2008cites this paper
• Disease-modifying agents in the Sonya Slifka Longitudinal Multiple Sclerosis Study

  2008cites this paper
• 65 – Multiple sclerosis

  2008cites this paper
• Diagnostik und medikamentöse Therapie der multiplen Sklerose

  2007cites this paper
• Venom therapy in multiple sclerosis.

  2007cites this paper
• Diagnostik und medikamentöse Therapie der multiplen Sklerose

  2007cites this paper
• Activated microglia stimulate transcriptional changes in primary oligodendrocytes via IL-1beta.

  2006cites this paper